Bioactive peptides attenuate cardiac hypertrophy and fibrosis in spontaneously hypertensive rat hearts

Bioactive peptides attenuate cardiac hypertrophy and fibrosis in spontaneously hypertensive rat hearts

Alcalase potato protein hydrolysate (APPH), a nutraceutical food, might an have important role in anti-obesity activity. Recent studies from our lab indicated that APPH treatment had lipolysis stimulating activity and identified was an efficient anti-obesity diet ingredient. In this study we aim to...

Full description

Bibliographic Details
Main Authors:	Chih Yang Huang, Srinivasan Nithiyanantham, Jia Ying Liao, Wan Teng Lin
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Journal of Food and Drug Analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1021949819301024

Similar Items

Bioactive flavone fisetin attenuates hypertension associated cardiac hypertrophy in H9c2 cells and in spontaneously hypertension rats
by: Kuan-Ho Lin, et al.
Published: (2019-01-01)

KMUP-1 attenuates isoproterenol- and spontaneously hypertension-induced cardiac hypertrophy of rats
by: Ping-Ju Wu, et al.
Published: (2006)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
by: Si-Chi Xu, et al.
Published: (2017-01-01)

Pioglitazone Attenuates Vascular Fibrosis in Spontaneously Hypertensive Rats
by: Dengfeng Gao, et al.
Published: (2012-01-01)

Role of microRNAs in cardiac hypertrophy, myocardial fibrosis and heart failure
by: De-li Dong, et al.
Published: (2011-06-01)

Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension
by: Mariann Gyöngyösi, et al.
Published: (2017-10-01)

Pre-germinated brown rice and its extract protected cardiac function in spontaneously hypertensive rats with type II diabetes by attenuating cardiac inflammation and ameliorating cardiac hypertrophy
by: Yi-Chen Tu, et al.
Published: (2019)

Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
by: Ajit Magadum, et al.
Published: (2021-05-01)

Bioactive Peptide VHVV Upregulates the Long-Term Memory-Related Biomarkers in Adult Spontaneously Hypertensive Rats
by: Da-Tong Ju, et al.
Published: (2019-06-01)

Qingda granules attenuate hypertensive cardiac remodeling and inflammation in spontaneously hypertensive rats
by: Xiangyan Wu, et al.
Published: (2020-09-01)

Exercise training attenuates hypertension and cardiac hypertrophy by modulating neurotransmitters and cytokines in hypothalamic paraventricular nucleus.
by: Lin-Lin Jia, et al.
Published: (2014-01-01)

Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats
by: Marcelo D.M. Cezar, et al.
Published: (2015-07-01)

Anti-Apoptosis and Anti-Fibrosis Effects of Eriobotrya Japonica in Spontaneously Hypertensive Rat Hearts
by: Jui-Ting Chiang, et al.
Published: (2018-05-01)

Epigenetics in Cardiac Hypertrophy and Heart Failure
by: Chia-Feng Liu, PhD, et al.
Published: (2019-12-01)

Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis
by: Juan Wang, et al.
Published: (2016-05-01)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
by: Yan Wang, et al.
Published: (2020-11-01)

TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ Upregulation
by: Feng Gao, et al.
Published: (2014-01-01)

Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
by: Tingwei Zhao, et al.
Published: (2021-04-01)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
by: Xinji Guo, PhD, et al.
Published: (2020-01-01)

RNA methylation in Cardiac Hypertrophy and Heart Failure
by: Buchholz, Eric
Published: (2020)

TRANSCRIPTIONAL REGULATION OF CARDIAC HYPERTROPHY AND HEART FAILURE
by: XU, JIAN
Published: (2006)

Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.
by: Liming Pan, et al.
Published: (2017-01-01)

IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.
by: Jia Dai, et al.
Published: (2013-01-01)

The antihypertensive effect and mechanisms of bioactive peptides from Ruditapes philippinarum fermented with Bacillus natto in spontaneously hypertensive rats
by: Yahui Song, et al.
Published: (2021-04-01)

Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
by: Qiaoling Li, et al.
Published: (2016-01-01)

Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro
by: Ningning Zhang, et al.
Published: (2019-01-01)

Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis
by: Xutao Sun, et al.
Published: (2021-01-01)

A Peptide-Functionalized Magnetic Nanoplatform-Loaded Melatonin for Targeted Amelioration of Fibrosis in Pressure Overload-Induced Cardiac Hypertrophy
by: Zhao X, et al.
Published: (2020-02-01)

Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats.
by: P L M Dalpiaz, et al.
Published: (2015-01-01)

Synergistic cardiac pathological hypertrophy induced by high-salt diet in IGF-IIRα cardiac-specific transgenic rats.
by: Ruey-Lin Chang, et al.
Published: (2019-01-01)

Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart
by: Yiping Xu, et al.
Published: (2014-10-01)

The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
by: Hsiang-Chun Lee, et al.
Published: (2019-04-01)

CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signaling.
by: Liang Yang, et al.
Published: (2013-01-01)

Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway
by: Yintao Chen, et al.
Published: (2018-04-01)

Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy
by: Carlos dos Santos Moreira, et al.
Published: (2015-05-01)

Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy
by: Carlos dos Santos Moreira, et al.
Published: (2015-05-01)

Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis
by: Chaoliang Tang, et al.
Published: (2020-09-01)

The cardiopulmonary reflexes of spontaneously hypertensive rats are normalized after regression of left ventricular hypertrophy and hypertension
by: T.A. Uggere, et al.
Published: (2000-05-01)

Collagen metabolism in normal heart and during cardiac hypertrophy
by: Turner, J. E.
Published: (1988)

The role of cardiac myocyte dimensions in the transition from hypertensive hypertrophy to cardiac dilatation
by: Jose Correia, Paul
Published: (2011)